706 results on '"Ducharme, Anique"'
Search Results
2. Interleukin-6 and Cardiovascular Events in Healthy Adults: MESA
3. An ISHLT consensus statement on strategies to prevent and manage hemocompatibility related adverse events in patients with a durable, continuous-flow ventricular assist device
4. International Society for Heart and Lung Transplantation Guidelines for the Evaluation and Care of Cardiac Transplant Candidates—2024
5. Clinical Heart fAilure Management Program: Changing the practice by partnering primary care and specialists (CHAMP-HF)
6. Access to Heart Failure Services in Canada: Findings of the Heart and Stroke National Heart Failure Resources and Services Inventory
7. Hemodynamic-Guided Heart Failure Management in Patients With Either Prior HF Hospitalization or Elevated Natriuretic Peptides
8. Extracorporeal membrane oxygenation and microaxial left ventricular assist device in cardiogenic shock: Choosing the right mechanical circulatory support to improve outcomes
9. Canadian Cardiovascular Society-Canadian Heart Failure Society Focused Clinical Practice Update of Patients With Differing Heart Failure Phenotypes
10. Optimization of pharmacotherapies for ambulatory patients with heart failure and reduced ejection fraction is associated with improved outcomes
11. Hemodynamically-Guided Management of Heart Failure Across the Ejection Fraction Spectrum: The GUIDE-HF Trial
12. The Evolution of Transcatheter Therapies for Mitral Valve Disease: From Mitral Valvuloplasty to Transcatheter Mitral Valve Replacement
13. Cas grave de myocardite apres vaccination anti-SRAS-CoV-2 chez une femme de 49 ans
14. Severe myocarditis after SARS-CoV-2 vaccination in a 49-year-old woman
15. Implantable Hemodynamic Monitors Improve Survival in Patients With Heart Failure and Reduced Ejection Fraction
16. Impact of clinical variables on outcomes in refractory cardiac arrest patients undergoing extracorporeal cardiopulmonary resuscitation
17. Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial
18. Optimizing Timing of Valve Intervention in Patients With Asymptomatic Severe Valvular Heart Disease
19. CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction
20. Care Gaps in Adherence to Heart Failure Guidelines: Clinical Inertia or Physiological Limitations?
21. Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis
22. Canadian Cardiovascular Society/Canadian Cardiac Transplant Network Position Statement on Heart Transplantation: Patient Eligibility, Selection, and Post-Transplantation Care
23. CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis
24. Optimization of GDMT for patients with heart failure and reduced ejection fraction: can physiological and biological barriers explain the gaps in adherence to heart failure guidelines?
25. Current Review of Implantable Cardioverter Defibrillator Use in Patients With Left Ventricular Assist Device
26. Psychosocial assessment tools for use before transplantation are predictive of post-operative psychosocial and health behavior outcomes: a narrative review of the literature
27. We Must Change Our Approach to Decongestion in Acute Heart Failure
28. Left Ventricular Outflow Tract Obstruction Following Mitral Valve Replacement: Challenges for Transcatheter Mitral Valve Therapy
29. Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease
30. Setting Up a Heart Failure Program in 2018: Moving Towards New Paradigm(s)
31. Changes in Outcomes of Cardiac Allograft Vasculopathy Over 30 Years Following Heart Transplantation
32. Barriers to Goals of Care Discussions With Patients Who Have Advanced Heart Failure: Results of a Multicenter Survey of Hospital-Based Cardiology Clinicians
33. 2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure
34. Impact of Left Ventricular vs Biventricular Pacing on Reverse Remodelling: Insights From the Evaluation of Resynchronization Therapy for Heart Failure (EARTH) Trial
35. Markers and Correlates of Right Ventricular Function with Computed Tomography, Echocardiography, and Magnetic Resonance
36. Preoperative Optimization of the Heart Failure Patient Undergoing Cardiac Surgery
37. Experience with the SynCardia total artificial heart in a Canadian centre
38. Changes in patient characteristics following cardiac transplantation: the Montreal Heart Institute experience
39. Transcatheter valvular therapies in patients with left ventricular assist devices
40. SEX-SPECIFIC EFFECTS OF HEMODYNAMIC-GUIDED MANAGEMENT ON HEART FAILURE OUTCOMES: A POOLED ANALYSIS FROM THE CHAMPION AND GUIDE-HF TRIALS
41. Emerging concepts in heart failure management and treatment: circulatory support with extracorporeal membrane oxygenation (ECMO)
42. Growth Differentiation Factor-15 as a Predictor of Functional Capacity, Frailty, and Ventricular Dysfunction in Patients With Aortic Stenosis and Preserved Left Ventricular Ejection Fraction
43. The Canadian Cardiovascular Society Heart Failure Companion: Bridging Guidelines to Your Practice
44. Surgical Experience and Long-term Results of Baroreflex Activation Therapy for Heart Failure With Reduced Ejection Fraction
45. The Medical Treatment of New-Onset Peripartum Cardiomyopathy: A Systematic Review of Prospective Studies
46. Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction
47. The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: Anemia, Biomarkers, and Recent Therapeutic Trial Implications
48. Thirty-year trends and outcome of isolated versus combined group 2 pulmonary hypertension after cardiac transplantation
49. Key questions about aortic insufficiency in patients with durable left ventricular assist devices
50. Association Between Right Ventricular Dysfunction and Adverse Outcomes in Peripartum Cardiomyopathy: Insights From the BRO-HF Quebec Cohort Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.